Outlive the Average
Quick, actionable longevity insights delivered weekly.
25 Week, 2025: Haenkenium outperforms resveratrol and single gene SB000 reverses cellular aging safely
Jun 16, 2025 · 5 min
Last week’s longevity research revealed multiple exciting advances perfectly aligned with the goals of busy knowledge workers seeking science-backed, time-efficient strategies to extend healthspan. Swiss and Italian researchers showcased Haenkenium, a plant extract that excels at clearing senescent cells and boosting skin and vascular functions more effectively than well-known compounds like resveratrol. Meanwhile, Shift Bioscience identified a single gene, SB000, capable of reversing cellular aging without the risks of pluripotency, marking a safer path for rejuvenation. Complementing these, novel protein treatments, synergistic drug combinations, clinically validated peptides, and everyday antioxidant-rich foods also demonstrated promising health benefits. Finally, a simple supplement regimen showed potential to reverse biological age, underscoring accessible approaches that integrate seamlessly into a busy lifestyle.Haenkenium extract stands out with its potent ability to clear senescent cells and improve skin and metabolic health, paving the way for more effective anti-aging therapies. This breakthrough highlights how targeted senolytics might soon transform age-related interventions for busy individuals.
Haenkenium Extract Outperforms Resveratrol and Quercetin
Researchers from Swiss and Italian institutions demonstrate in cell and animal models that Haenkenium, an extract from Salvia haenkei, exhibits superior senolytic activity compared to resveratrol and quercetin. By selectively clearing senescent cells, Haenkenium enhances skin elasticity, metabolic functions, and vascular performance, positioning it as a promising candidate for next-generation anti-aging therapies.
Key points:
- Haenkenium shows dose-dependent clearance of senescent cells in skin, liver, and vascular endothelium models.
- It outperforms resveratrol and quercetin by reducing inflammatory markers and restoring tissue function without significant side effects.
- Animal studies reveal multi-tissue benefits, including improved skin elasticity, metabolic health, and vascular performance.
Why it matters: Haenkenium’s superior senolytic potency could shift age-related therapy paradigms by enabling more effective and targeted clearance of senescent cells.
Single Gene SB000 Matches Yamanaka Factors for Safe Cellular Rejuvenation
A team at Shift Bioscience employs a novel single-cell transcriptomic clock (AC3) to screen 1,500 genes, discovering SB000 as a single-factor intervention that reverses transcriptomic and epigenetic aging in fibroblasts and keratinocytes without activating pluripotency, paving the way for safe rejuvenation therapies.
Key points:
- AC3 single-cell transcriptomic clock screens 1,500 ORFs to identify rejuvenation factors.
- SB000 expression reduces transcriptomic age by ~4.5 years in fibroblasts and keratinocytes without pluripotency.
- SB000 reverses multiple epigenetic clocks and increases global CpG methylation by ~3%, preserving cell identity.
Why it matters: SB000 decouples cell rejuvenation from pluripotency, offering a safer, single-gene route to reverse aging across diverse tissues.
s-KL Protein Extends Mouse Lifespan by 20%
Klotho Neurosciences has demonstrated that their adeno-associated virus (AAV9) platform delivers the secreted form of the Klotho protein (s-KL) to increase circulating levels, resulting in a 20% extension of healthy lifespan in mice. Building on foundational work linking Klotho to aging, this approach targets multiple age-associated pathologies—including cognitive decline, neuroinflammation, sarcopenia, and osteoporosis—offering a unified therapeutic strategy.
Key points:
- AAV9-mediated delivery of secreted Klotho (s-KL) increases mouse lifespan by 20%.
- Overexpression of full-length Klotho gene extends murine lifespan by 30–40%.
- s-KL therapy mitigates cognitive decline, neuroinflammation, sarcopenia, and osteoporosis.
Why it matters: Demonstrating a single protein-based therapy that extends healthy lifespan and ameliorates multiple age-related diseases marks a paradigm shift in anti-aging therapeutics.
Rapamycin-Trametinib Combo Extends Mouse Lifespan Up to 35%
Researchers at the Max Planck Institute evaluate the lifespan impact of rapamycin and trametinib, singly and in combination, in mouse models. They observe that combined administration yields a 26–35% lifespan increase by modulating distinct nodes in the Ras/Insulin/TOR signaling network, with added benefits for tumor suppression and reduced inflammation.
Key points:
- Combined administration of rapamycin and trametinib extends mouse lifespan by 26–35%.
- Drugs act on distinct nodes within the Ras/Insulin/TOR signaling network to enhance geroprotection.
- Treatment delays liver and spleen tumor growth and reduces chronic brain inflammation in mice.
Why it matters: Demonstrating additive geroprotective effects in mice highlights a translational strategy for combinatorial drug repurposing to delay human aging and age-related diseases.
Clinically Validated Peptides Advance Longevity and Cellular Repair
A consortium of clinical researchers demonstrates that short-chain peptides serve as precise signaling molecules to modulate tissue repair, immune function, and metabolic regulation. Validated in human trials, these peptides enhance cellular resilience and support healthspan through targeted delivery and dosing protocols.
Key points:
- BPC-157 and TB-500 enhance tissue repair and gut barrier support in preclinical and human studies via localized administration.
- Epitalon extends telomere length and regulates circadian rhythms while MOTS-c boosts mitochondrial function to improve metabolic and exercise recovery.
- Personalized peptide stacks, including CJC-1295/Ipamorelin, modulate growth hormone axes to maintain muscle mass and facilitate fat loss under biomarker guidance.
Why it matters: Validated peptide therapies offer precise, mechanism-based interventions that improve healthspan and resilience beyond traditional supplements.
Grocery Staples Deliver Powerful Anti-Aging Effects
A coalition of health researchers reviews clinical studies demonstrating that regular consumption of antioxidant-dense foods—including watercress, red bell peppers, and blueberries—enhances collagen production, reduces inflammatory markers, and improves skin elasticity through synergistic nutrient interactions.
Key points:
- Watercress delivers high concentrations of vitamins A and C, boosting collagen synthesis by 30% and improving skin elasticity in human trials.
- Red bell peppers’ carotenoids and vitamin C reduce UV and pollution-induced skin damage by 35% through synergistic antioxidant activity.
- Blueberries’ anthocyanins neutralize free radicals, prevent collagen degradation, and inhibit glycation, leading to measurable enhancements in skin texture.
Why it matters: This dietary approach shifts anti-aging strategies from topical treatments to affordable, nutrient-based interventions with broad health benefits.
Doctor Reverses Age with Three Key Supplements
The HUM2N clinic’s founder, Dr. Mohammed Enayat, credits a regimen of vitamin B complex, magnesium, and omega-3 fatty acids with reversing his biological age. These supplements work by enhancing energy metabolism, regulating enzymatic processes, and combating inflammation, which collectively promote cellular vitality and resilience.
Key points:
- Vitamin B complex enhances energy metabolism, DNA repair, and nervous system function.
- Magnesium regulates over 300 enzymatic reactions, improves sleep, and mitigates inflammation.
- Omega-3 fatty acids (EPA/DHA) reduce systemic inflammation and support cardiovascular and brain health.
Why it matters: This approach suggests affordable, non-invasive strategies can modulate cellular aging markers and inflammation, potentially transforming preventive healthcare and broadening therapeutic options in longevity research.
